$0.96
4.00% today
Nasdaq, Apr 03, 06:36 pm CET
ISIN
US67113Y1082
Symbol
NUWE

Nuwellis Inc Stock price

$1.00
-0.20 16.67% 1M
-0.48 32.43% 6M
-0.11 9.91% YTD
-12.34 92.50% 1Y
-3,568.30 99.97% 3Y
-46,619.00 100.00% 5Y
-3,730,859,999.00 100.00% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+0.04 4.38%
ISIN
US67113Y1082
Symbol
NUWE
Sector

Key metrics

Market capitalization $4.37m
Enterprise Value $-180.00k
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.02
EV/Sales (TTM) EV/Sales -0.02
P/S ratio (TTM) P/S ratio 0.50
P/B ratio (TTM) P/B ratio 0.67
Revenue growth (TTM) Revenue growth -1.40%
Revenue (TTM) Revenue $8.74m
EBIT (operating result TTM) EBIT $-10.99m
Free Cash Flow (TTM) Free Cash Flow $-9.65m
Cash position $5.10m
EPS (TTM) EPS $-38.64
P/E forward negative
P/S forward 0.40
EV/Sales forward negative
Short interest 4.07%
Show more

Is Nuwellis Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Nuwellis Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Nuwellis Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Nuwellis Inc:

Buy
100%

Financial data from Nuwellis Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
8.74 8.74
1% 1%
100%
- Direct Costs 3.06 3.06
21% 21%
35%
5.68 5.68
14% 14%
65%
- Selling and Administrative Expenses 13 13
22% 22%
150%
- Research and Development Expense 3.21 3.21
41% 41%
37%
-11 -11
38% 38%
-122%
- Depreciation and Amortization 0.31 0.31
14% 14%
4%
EBIT (Operating Income) EBIT -11 -11
38% 38%
-126%
Net Profit -11 -11
45% 45%
-128%

In millions USD.

Don't miss a Thing! We will send you all news about Nuwellis Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nuwellis Inc Stock News

Neutral
Seeking Alpha
23 days ago
Nuwellis, Inc. (NASDAQ:NUWE ) Q4 2024 Earnings Conference Call March 11, 2025 9:00 AM ET Company Participants Vivian Cervantes - Gilmartin Group, Investor Relations John Erb - Interim President and Chief Executive Officer Rob Scott - Chief Financial Officer Conference Call Participants Jonathan Aschoff - Roth Anthony Vendetti - Maxim Group Operator Good morning. And welcome to Nuwellis Earnings...
Neutral
GlobeNewsWire
23 days ago
MINNEAPOLIS, March 11, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical device company focused on transforming the lives of people with fluid overload, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Neutral
GlobeNewsWire
about one month ago
John Erb, Current Chair of the Board, Appointed Interim President and CEO John Erb, Current Chair of the Board, Appointed Interim President and CEO
More Nuwellis Inc News

Company Profile

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Head office United States
CEO John Erb
Employees 38
Founded 1999
Website www.nuwellis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today